NASDAQ:MDGL

Madrigal Pharmaceuticals Stock Insider Trading

etoro logo Buy MDGL
*Your capital is at risk
$467.32
-25.79 (-5.23%)
At Close: Jul 31, 2026

Madrigal Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -22.27. In total, the insiders bought 224.94K and sold 42.5K MDGL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-22.27
Buy 224.94K shares
Sell 42.5K shares
35% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Jul 17, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -22.27.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jul 20, 2026
Sell
Common Stock
S-Sale
Sibold William John
President And CEO
CEO / President 110
Value: $59.8K
Jul 20, 2026
Sell
Common Stock
S-Sale
Sibold William John
President And CEO
CEO / President 140
Value: $76.0K
Jul 20, 2026
Sell
Common Stock
S-Sale
Sibold William John
President And CEO
CEO / President 280
Value: $155.4K
Jul 20, 2026
Sell
Common Stock
S-Sale
Sibold William John
President And CEO
CEO / President 153
Value: $84.2K
Jul 20, 2026
Sell
Common Stock
S-Sale
Sibold William John
President And CEO
CEO / President 275
Value: $150.1K
Jul 20, 2026
Sell
Common Stock
S-Sale
Sibold William John
President And CEO
CEO / President 269
Value: $147.2K
Jul 20, 2026
Sell
Common Stock
S-Sale
Sibold William John
President And CEO
CEO / President 680
Value: $372.4K
Jul 20, 2026
Sell
Common Stock
S-Sale
Sibold William John
President And CEO
CEO / President 47
Value: $25.8K
Jul 20, 2026
Sell
Common Stock
S-Sale
Sibold William John
President And CEO
CEO / President 1
Value: $551
Jul 20, 2026
Sell
Common Stock
S-Sale
Sibold William John
President And CEO
CEO / President 545
Value: $296.9K
Jul 17, 2026
Buy
Performance Restricted Stock Units
M-Exempt
Sibold William John
President And CEO
CEO / President 50 000
Value: $27.7M
Jul 17, 2026
Buy
Common Stock
M-Exempt
Sibold William John
President And CEO
CEO / President 50 000
Value: $27.7M
Jun 17, 2026
Buy
Non-Qualified Stock Options (right to buy)
A-Award
Baker Bros. Advisors Lp
Director
Director 1 532
Value: $765.8K
Jun 17, 2026
Buy
Common Stock
A-Award
Baker Bros. Advisors Lp
Director
Director 908
Value: $453.9K
Jun 17, 2026
Buy
Stock Option (Right to Buy)
A-Award
Brennan Daniel J.
Director
Director 681
Value: $340.4K
Jun 17, 2026
Buy
Stock Option (Right to Buy)
A-Award
Daly James M
Director
Director 766
Value: $382.9K
Jun 17, 2026
Buy
Common Stock
A-Award
Daly James M
Director
Director 454
Value: $226.9K
Jun 17, 2026
Buy
Common Stock
A-Award
Fouse Jacqualyn A
Director
Director 454
Value: $226.9K
Jun 17, 2026
Buy
Stock Option (Right to Buy)
A-Award
Levy Richard S
Director
Director 766
Value: $382.9K
Jun 17, 2026
Buy
Stock Option (Right to Buy)
A-Award
Taub Rebecca
Director
Director 766
Value: $382.9K
Jun 17, 2026
Buy
Common Stock
A-Award
Taub Rebecca
Director
Director 454
Value: $226.9K
Jun 17, 2026
Buy
Common Stock
A-Award
Levy Richard S
Director
Director 454
Value: $226.9K
Jun 17, 2026
Buy
Stock Option (Right to Buy)
A-Award
Fouse Jacqualyn A
Director
Director 766
Value: $382.9K
Jun 17, 2026
Buy
Common Stock
A-Award
Brennan Daniel J.
Director
Director 404
Value: $201.9K
Jun 17, 2026
Buy
Common Stock
A-Award
Baker Bros. Advisors Lp
Director
Director 908
Value: $453.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT MADRIGAL PHARMACEUTICALS, INC.
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745,...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE